BB Biotech as of Sept. 30, 2011
Portfolio Holdings for BB Biotech
BB Biotech holds 20 positions in its portfolio as reported in the September 2011 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Celgene Corporation | 22.6 | $192M | 3.1M | 61.91 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 14.2 | $121M | 2.7M | 44.46 | |
Gilead Sciences (GILD) | 11.9 | $101M | 2.6M | 38.80 | |
Incyte Corporation (INCY) | 7.7 | $65M | 4.7M | 13.97 | |
ImmunoGen (IMGN) | 5.2 | $44M | 4.0M | 10.96 | |
ISIS Pharmaceuticals | 4.5 | $38M | 5.6M | 6.78 | |
Pharmasset | 3.9 | $33M | 398k | 82.37 | |
Micromet | 3.8 | $32M | 6.7M | 4.80 | |
BioMarin Pharmaceutical (BMRN) | 3.6 | $31M | 976k | 31.87 | |
Halozyme Therapeutics (HALO) | 3.6 | $31M | 5.0M | 6.14 | |
Alexion Pharmaceuticals | 3.4 | $29M | 450k | 64.06 | |
Amylin Pharmaceuticals | 2.6 | $22M | 2.4M | 9.23 | |
Optimer Pharmaceuticals | 2.4 | $20M | 1.4M | 13.84 | |
Human Genome Sciences | 2.3 | $20M | 1.6M | 12.69 | |
Theravance | 2.0 | $17M | 843k | 20.14 | |
Amgen (AMGN) | 1.9 | $17M | 300k | 54.96 | |
Dendreon Corporation | 1.6 | $14M | 1.5M | 9.00 | |
Idenix Pharmaceuticals | 1.5 | $12M | 2.5M | 4.99 | |
Achillion Pharmaceuticals | 1.1 | $9.5M | 2.0M | 4.72 | |
Endocyte | 0.4 | $3.3M | 308k | 10.60 |